Results for tag: "Apremilast"

Apremilast is a small molecule drug used to treat psoriasis, a chronic skin condition. It is a phosphodiesterase 4 (PDE4) inhibitor, which works by blocking the action of an enzyme that is involved in inflammation. Apremilast is taken orally and is available in tablet form. It is generally used in combination with other treatments, such as topical corticosteroids or phototherapy. Apremilast is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2014. It is the only oral PDE4 inhibitor approved for the treatment of psoriasis. It has been found to be effective in reducing the symptoms of psoriasis, including itching, redness, and scaling. The Apremilast market is growing, as more patients are turning to this drug as an alternative to traditional treatments. It is becoming increasingly popular due to its convenience and effectiveness. Some companies in the Apremilast market include Celgene Corporation, Sun Pharmaceutical Industries, and Mylan N.V. Show Less Read more